Skip to content

ALP

AlphaTON Capital Corp.

NASDAQ · Healthcare · Biotechnology · VG

$0.10
−13.74%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue97.0K97.0K
Cost of Revenue35.0K54.0K1.0K
Gross Profit97.0K97.0K(35.0K)(54.0K)(1.0K)
Operating Expenses
R&D Expense2.7M2.8M3.1M12.5M8.2M
SG&A Expense21.7M20.2M4.3M5.7M8.4M
General & Admin Expense21.7M20.2M4.3M5.7M8.4M
Selling & Marketing Expense
Other Expenses193.0K193.0K
Total Operating Expenses24.6M23.2M7.4M18.2M16.6M
Cost and Expenses24.6M23.2M7.4M18.3M16.6M
Operating Income (EBIT)(24.5M)(23.1M)(7.4M)(18.3M)(16.6M)
Non-Operating
Interest Income5.0K89.0K274.0K217.0K
Interest Expense1.0M1.0M3.0K32.0K9.0K
Net Interest Income(1.0M)(1.0M)86.0K242.0K208.0K
Other Non-Op Income/Expense(18.9M)(15.5M)637.0K(67.4M)(105.9M)
Non-Operating Income (excl Interest)8.3M(14.5M)(640.0K)54.0K105.7M
EBT (Pre-Tax Income)(43.4M)(38.6M)(6.8M)(85.7M)(122.5M)
Income Tax Expense(3.0K)(10.5M)(17.9M)
Bottom Line
Net Income(43.4M)(38.6M)(6.8M)(75.3M)(104.6M)
Earnings from Cont. Ops(43.4M)(38.6M)(6.8M)(75.1M)(104.7M)
Earnings from Discont. Ops
Bottom Line Net Income(43.4M)(38.6M)(6.8M)(75.3M)(104.6M)
Per Share
Basic EPS($8.38)($4.18)($5.72)($3.70)($6.49)
Diluted EPS($8.38)($4.18)($5.72)($3.70)($6.49)
Revenue Per Share$0.01$0.01$0.00$0.00$0.00
Shares
Basic Shares Outstanding16.3M9.2M1.2M20.3M16.1M
Diluted Shares Outstanding16.3M9.2M1.2M20.3M16.1M
Profitability Metrics
EBITDA(32.8M)(8.4M)(6.7M)(18.2M)(122.3M)
D&A48.8K193.0K35.0K54.0K1.0K
EBIT(32.9M)(8.6M)(6.8M)(18.3M)(122.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026